View source for COPD-LONG TERM OXYGEN THERAPY

===== [[Summary Article|'''SUMMARY''']] =====
1. Given 16 hr/day; anything &lt; 15 hr/day does not confer a survival advantage.
<br/>
<br/>2. Improves dyspnoea, exercise capacity, quality of life.
<br/>
<br/>3. Patients should be encouraged to be active as this improves mortality/morbidity; however difficult as O<sub>2</sub> delivery systems are bulky. 
<br/>
<br/>4. LTOT for nocturnal dyspnoea improves sleep quality &amp; decreases number of nocturnal PVCs. 
<br/> 5. Continuous O2 therapy indicated in PaO2 &lt; 55 mmHg or PaO2 &lt; 60 mmHg with pulmonary HTN or cor pulmonale.


==Reference(s)==
Wilkinson, I., Furmedge, D. and Sinharay, R. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press. [https://amzn.to/3YHrI6K Get it on Amazon.]
<br/>Feather, A., Randall, D. and Waterhouse, M. (2020). Kumar And Clark’s Clinical Medicine. 10th ed. S.L.: Elsevier Health Sciences. [https://amzn.to/3k7WSW0 Get it on Amazon.]
<br/>Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy.
<br/>Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. https://www.tg.org.au [Accessed 2021].

[[Category:Copd]]
[[Category:Respiratory]]
[[Category:Medicine]]